Polycystic kidney disease: new understanding in the pathogenesis.

Polycystic kidney disease (PKD) is a disease of the nephron, characterized by the formation of multiple renal tubular cysts, leading to endstage renal failure. The most common form is autosomal dominant PKD (ADPKD) and is caused by mutations in the PKD1 gene in 85% of cases or in PKD2 in 10-15%. Rarer forms include autosomal recessive PKD (ARPKD) and nephronophthisis with high mortality and morbidity in children. Recent advances suggest that the PKD1-encoded protein, polycystin-1, is a renal epithelial cell membrane mechanoreceptor, sensing morphogenetic cues in the extracellular environment at the basal surface in focal adhesion complexes; at the lateral surface in cell adherens junctions; and in the lumen at the apical primary cilium. Activation via multiprotein complex formation, intracellular signal transduction cascades and regulation of fetal gene transcription leads to appropriate renal tubule epithelial cell division and differentiation in normal kidneys, but is disrupted in PKD resulting in cyst formation.

[1]  P. Wilson,et al.  Modification of the composition of polycystin-1 multiprotein complexes by calcium and tyrosine phosphorylation. , 2000, Biochimica et biophysica acta.

[2]  A. Woolf,et al.  Taxol inhibits progression of congenital polycystic kidney disease , 1994, Nature.

[3]  P. Gabow,et al.  Autosomal dominant polycystic kidney disease. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[4]  L. Guay-Woodford,et al.  The polycystic kidney disease proteins, polycystin-1, polycystin-2, polaris, and cystin, are co-localized in renal cilia. , 2002, Journal of the American Society of Nephrology : JASN.

[5]  Weining Lu,et al.  Perinatal lethality with kidney and pancreas defects in mice with a targetted Pkd1 mutation , 1997, Nature Genetics.

[6]  Jing Zhou,et al.  Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells , 2003, Nature Genetics.

[7]  Y Chen,et al.  Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor. , 2000, Kidney international.

[8]  M. R. Islam,et al.  The Polycystic Kidney Disease-1 Promoter Is a Target of the β-Catenin/T-cell Factor Pathway* , 2002, The Journal of Biological Chemistry.

[9]  T. Strachan,et al.  Mutations in INVS encoding inversin cause nephronophthisis type 2, linking renal cystic disease to the function of primary cilia and left-right axis determination , 2003, Nature Genetics.

[10]  P. Wilson,et al.  Polycystic kidney disease. , 2004, The New England journal of medicine.

[11]  Vincent H Gattone,et al.  Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist , 2003, Nature Medicine.

[12]  P. Wilson,et al.  Polycystin: New Aspects of Structure, Function, and Regulation Structure of Polycystin-1 , 2022 .

[13]  J. Sharpe,et al.  A human PKD1 transgene generates functional polycystin-1 in mice and is associated with a cystic phenotype. , 2000, Human molecular genetics.

[14]  P. Igarashi,et al.  Genetics and pathogenesis of polycystic kidney disease. , 2002, Journal of the American Society of Nephrology : JASN.

[15]  E. Avner,et al.  Efficacy of taxol in the orpk mouse model of polycystic kidney disease , 1997, Pediatric Nephrology.

[16]  P. Harris Autosomal dominant polycystic kidney disease: clues to pathogenesis. , 1999, Human molecular genetics.